215 related articles for article (PubMed ID: 38524132)
1. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
3. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
[TBL] [Abstract][Full Text] [Related]
4. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
[TBL] [Abstract][Full Text] [Related]
6. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
7. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
Drake LY; Iijima K; Kita H
Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
[TBL] [Abstract][Full Text] [Related]
8. IL-33-ILC2 axis promotes anti-tumor CD8
Okuyama Y; Okajima A; Sakamoto N; Hashimoto A; Tanabe R; Kawajiri A; Kawabe T; Ishii N
Biochem Biophys Res Commun; 2022 Dec; 637():9-16. PubMed ID: 36375254
[TBL] [Abstract][Full Text] [Related]
9. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases.
Ikutani M; Nakae S
Front Immunol; 2022; 13():939378. PubMed ID: 35844571
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
12. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.
Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q
EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128
[TBL] [Abstract][Full Text] [Related]
13. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
14. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
17. Group 2 innate lymphoid cells boost CD8
Wen J; Cheng S; Wang R; Huang Y; Xu L; Ma L; Ling Z; Xu J; Zhao D; Zhang Y; Sun B
Oncoimmunology; 2023; 12(1):2243112. PubMed ID: 37577145
[TBL] [Abstract][Full Text] [Related]
18. IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2.
Olguín-Martínez E; Muñoz-Paleta O; Ruiz-Medina BE; Ramos-Balderas JL; Licona-Limón I; Licona-Limón P
Front Immunol; 2022; 13():787713. PubMed ID: 35711429
[TBL] [Abstract][Full Text] [Related]
19. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
[TBL] [Abstract][Full Text] [Related]
20. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8
Wan J; Wu Y; Huang L; Tian Y; Ji X; Abdelaziz MH; Cai W; Dineshkumar K; Lei Y; Yao S; Sun C; Su Z; Wang S; Xu H
Cancer Lett; 2021 Apr; 502():34-43. PubMed ID: 33429004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
